AmeriFlex Group’s CorMedix CRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$683 Hold
87
﹤0.01% 1469
2026
Q1
$591 Hold
87
﹤0.01% 1016
2025
Q4
$1.01K Sell
87
-87
-50% -$962 ﹤0.01% 1031
2025
Q3
$2.02K Buy
174
+24
+16% +$290 ﹤0.01% 976
2025
Q2
$2.24K Hold
150
﹤0.01% 948
2025
Q1
$924 Buy
+150
New +$1.55K ﹤0.01% 1205

Other funds holding CRMD

AmeriFlex Group's CRMD Position: Q2 2026 in Review

AmeriFlex Group held its CorMedix (CRMD) position steady in Q2 2026 at 87 shares worth $683. The position accounts for ﹤0.01% of the portfolio, ranked #1469.

AmeriFlex Group first reported a position in CRMD in Q1 2025 and has held it in 6 quarters since. The position peaked at $2.24K in Q2 2025. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • AmeriFlex Group held 87 shares of CorMedix worth $683 as of Q2 2026.
  • AmeriFlex Group left its CorMedix share count unchanged in Q2 2026.
  • CorMedix made up ﹤0.01% of AmeriFlex Group's portfolio in Q2 2026, its #1469 holding.
  • AmeriFlex Group first reported a position in CorMedix in Q1 2025 and has held it in 6 quarters since.
  • AmeriFlex Group's CorMedix position peaked at $2.24K in Q2 2025.
  • 194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on AmeriFlex Group's 13F filing for Q2 2026, filed 14 Aug 2026.